Stay updated with breaking news from Patrick Alexandre. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dijon, February 27, 2024 at 8:30am Crossject obtains a financing up to €12 million, in two tranches,from an entity managed by Heights Capital Management, in issued bondsconvertible in new shares,...
Focusing on regulatory filings and accelerating U.S. commercialization efforts Contract of up to $155 million with BARDA for U.S. stockpiling continues to advance Dijon, France February 6, 2024...
Dijon, France, February 1, 2024 -- 18:15 CET - Crossject , a specialty pharma company developing needle-free auto-injectors for emergency situations, will hold a conference call on its commercial...
Dijon, France, February 1, 2024 -- 18:15 CET - Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharma company developing needle-free...
Press Release Crossject engages Syneos Health for U.S. commercial launch of ZEPIZURE® Crossject expanding market access activities in preparation for filing for marketing...